LFCR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

LF

Mkt Cap

$242.0M

Volume

1.40M

Loading chart

LF

LFCRLifecore Biomedical, Inc. Common Stock

LFCR

Pay with—

Available Balance0.00

LF

Mkt Cap

$244.1M

Volume

1.40M

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether MISTRAS Group's $20.35/share sale to H.I.G. Capital, Lifecore Biomedical's $6.28/share sale to Webster Equity Partners, and Marygold Companies' $2.00/share sale to Madison Dearborn Partners represent fair deals for shareholders. The firm may seek increased consideration, additional disclosures, and other relief on behalf of shareholders.GlobeNewswire Inc. · Oct 4, 2026

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCRA proposed class action settlement of $3,750,000 has been reached on behalf of purchasers of Lifecore Biomedical, Inc. (NASDAQ: LFCR) securities between October 7, 2020, and March 19, 2024. The settlement requires court approval at a hearing scheduled for July 28, 2026. Class members must submit claim forms by July 7, 2026, to be eligible for distribution from the settlement fund.GlobeNewswire Inc. · Apr 6, 2026

Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics CompanyLifecore Biomedical announced it has signed a CDMO manufacturing services agreement with a new aesthetics customer for an established, market-approved product. This is the company's third commercial site transfer since October 2025. The product is expected to generate commercial revenue within 24 months and contribute to Lifecore's targeted 2029 revenue CAGR of 12%. The agreement demonstrates successful execution of the company's strategy to secure lower-risk, late-stage programs with faster paths to commercial revenue.GlobeNewswire Inc. · Mar 23, 2026

Green Dot Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesJohnson Fistel, PLLP announced investigations into potential securities law violations by Green Dot Corporation, Lifecore Biomedical, and Horizon Technology Finance on behalf of affected investors. Green Dot's stock declined approximately 7% following the company's announcement of delayed financial results for Q4 and full year 2025.GlobeNewswire Inc. · Mar 17, 2026

Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesJohnson Fistel, PLLP announced investigations into three companies on March 16, 2026. Lifecore Biomedical issued disappointing 2026 revenue guidance of $120-125 million versus $141.4 million in 2025, citing customer loss and product launch delays, resulting in an 18% stock decline. The firm is also investigating Horizon Technology Finance and G-III Apparel Group for potential federal securities law violations.GlobeNewswire Inc. · Mar 16, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Lifecore Biomedical's compensation committee approved equity inducement grants on January 14, 2026, awarding 1,738 RSUs and 8,775 stock options to two newly hired employees. The RSUs vest after three years, while stock options vest monthly over three years with a seven-year exercise term.GlobeNewswire Inc. · Jan 16, 2026

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical CustomerLifecore Biomedical has signed a master services agreement with a new large global pharmaceutical customer to conduct development services and tech transfer for an injectable pharmaceutical product, potentially becoming a top five commercial customer.GlobeNewswire Inc. · Dec 17, 2025

Lifecore Biomedical to Participate at Upcoming Industry Conferences and EventsLifecore Biomedical will participate in three pharmaceutical industry conferences in October and November 2025, including PODD, CPHI Worldwide, and American Pharma Manufacturing & Outsourcing Summit, where they will host booth meetings and participate in panel discussions.GlobeNewswire Inc. · Oct 13, 2025

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmLaw firm investigating potential claims against LifeCore Biomedical for alleged false financial statements and internal control deficiencies during October 2020 to March 2024 period.GlobeNewswire Inc. · Sep 27, 2025

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmLaw firm investigating potential claims against LifeCore Biomedical for alleged false financial statements and internal control deficiencies during October 2020 to March 2024 period.GlobeNewswire Inc. · Aug 15, 2025

to start trading

LF

LFCRLifecore Biomedical, Inc. Common Stock

LFCR

Pay with—

Available Balance0.00

Your PositionYou don't own any LFCR yet.

Related Tickers

Earnings